Resource Library
Welcome to our resource library, a comprehensive collection of eBooks, white papers, case studies, on-demand webinars, and more.
Home
Resources
Four decades of thought leadership, deep academic roots, and strong alliances with industry experts enable us to offer unique insights into every aspect of the drug development cycle.
Explore our full range of resources to enhance your understanding of the therapy-defining power of data analytics and how they can help you make better-informed decisions, no matter where you are on your path to achieving improved patient outcomes.
Filters
Reset All filters
Asset type
Whitepapers
Webinars
eBook
Case Studies
Drug development Phases
Preclinical
Phase 3
Phase 2
Phase 1
Service type
Synthetic Controls
Submissions
Strategic Consulting
stève consultants
software
SLR
Simulations
RWE
RWD
Regulatory Affairs
Post-Marketing
Pediatrics
PBS
PASS
Optimization
Observational Study
Modeling
IRA
HTA
HEOR
FSP
External Controls
EVA
Epidemiology
East Horizon
East
East
Early Phase
Dose-Finding
Database Study
Data Monitoring Committees
Cost-effectiveness
Comparative Study
Biostatistics
Biometrics
Bayesian
AI
Adaptive Trial Design
Therapeutic Areas
Respiratory Diseases
Rare diseases
Oncology
Neurolomuscular Disorder
Neurological Disorder
Metabolic Disorders
Macular Degeneration
Liver Disease
Infectious Diseases
Cardiovascular
Blood Disorder
Autoimmune Disease
December 17, 2025
Read More
White Paper – Leveraging Cloud Computing and Advanced Software for Parameter Optimization of Multi-Arm Multi-Stage Designs
November 7, 2025
Read More
Case Study – Accelerating Chronic Pain Treatments Through Optimal Interim Analyses Timing in Adaptive Clinical Trial Design
October 16, 2025
Read More
Webinar – Rethinking Clinical Trials in Early Development: How External Controls Drive Ethical, Efficient Development
October 16, 2025
Read More
Case Study – Tailoring Statistical Services for Academic Clients and Unlocking Greater Value for Medical Research
October 15, 2025
Read More
White Paper – Randomized Controlled Trials Aren’t Enough Why Comparative Effectiveness is the New Strategic Imperative
October 9, 2025
Read More
Webinar – Leveraging the Right Advanced Quantitative Methods to Address Evidentiary Gaps
September 24, 2025
Read More
Webinar – The Role of Real-World Evidence in Addressing Post-Launch Needs
September 16, 2025
Read More
Webinar – FDA’s Project FrontRunner: Reshaping Oncology Drug Development
September 10, 2025
Read More
Webinar – Boosting Phase III Probability of Success with Informed Priors from Phase II Data
September 2, 2025
Read More
White Paper – Navigating the Evolving Landscape of Data Engineering and the Quest for Elusive Talent
September 1, 2025
Read More
White Paper – Optimizing Interim Analyses Considering Potential Enrollment Variations: A Cytel-GSK Trial Design Case Study
August 28, 2025
Read More
Webinar – How AI Enhances Biometrics Services: Streamlining Data Management and Improving Statistical Accuracy in Clinical Trials
July 10, 2025
Read More
Webinar – Navigating the First Year of EU JCA Implementation: Updates, Methodological Insights, and Bridging Local HTA Realities
June 11, 2025
Read More
White Paper – Clinical Trial SAS Programming Needs a Makeover: Agile Leads the Way
May 14, 2025
Read More
Webinar – From Toplines to Triumph: Visualizing the Pathways to Regulatory Approval
May 13, 2025
Read More
White Paper – ICH E20 Ushers in a New Era for Adaptive Designs in Clinical Development
May 8, 2025
Read More
Webinar – R-Integration Series Part 5: A Closer Look at Assurance: Sampling Patient Outcomes from Prior Distributions to Account for Uncertainty in Response Scenarios
May 7, 2025
Read More
Webinar – Maximizing the Value of the DMC: A Cost-Effective Approach to Safeguarding Clinical Development
April 15, 2025
Read More
Webinar – Winning in a Budget-Constrained World: Smarter Clinical Trial Optimization
March 24, 2025
Read More
White Paper – Faster Time to Market: Approaches to Biometrics for Emerging Biopharma Companies
March 20, 2025
Read More
Webinar – The Evolving Role of Statisticians: Leading Innovation as Clinical Data Scientists in the Age of the Reimagined RCT
March 13, 2025
Read More
eBook – Rare Disease Clinical Trials: Design Strategies and Regulatory Considerations
March 11, 2025
Read More
Webinar – The Evolving Landscape of Companion Diagnostics in Precision Medicine
March 6, 2025
Read More
R-Integration Series Part 4: Evaluating Different Analysis Options for Your Oncology Study Design by Combining East Horizon and R
February 27, 2025
Read More
Webinar – Physiologically-Based Pharmacokinetics (PBPK) Modeling and Simulation: A Transformative Tool for Early-Stage Clinical Development
February 13, 2025
Read More
Webinar – Accelerated HTA Timelines: Unlock the Power of Ready-to-Use SLRs
January 29, 2025
Read More
Case Study – Creating an Effective Functional Services Partnership
January 29, 2025
Read More
Case Study – Streamlining a Rare Disease Trial with Integrated Data Management
December 4, 2024
Read More
Webinar – Real-World Evidence in the Era of EU JCA: How to Target Several Countries with a Single Protocol
November 18, 2024
Read More
e-book – Navigating EU JCA Submissions and Local HTA Decision-Making
November 13, 2024
Read More
Webinar – Guide to Successful G-BA Consultations: Practical Tips for Market Access Professionals
October 31, 2024
Read More
Webinar – Aligning Clinical Development Strategy with Investment Priorities
October 29, 2024
Read More
Webinar – Oncology Drug Development under Project Optimus: Case Studies
October 15, 2024
Read More
Webinar – Reshaping the Product Launch Lifecycle to Embrace Health Equity in HEOR and Market Access Strategy: Current Trends, Methods, and Challenges/Solutions
October 9, 2024
Read More
Webinar – Oncology Clinical Trials: Design Considerations in Adaptive Population Enrichment Trials
September 30, 2024
Read More
White Paper- Exploring Treatment Effect Thresholds in Adaptive Trial Design
September 2, 2024
Read More
A Guide to Biometrics Resourcing in a Budget Constrained Life Sciences Industry
August 28, 2024
Read More
Oncology Clinical Trials: Design Trends in Biomarker-Driven Research
August 5, 2024
Read More
Exploring Basket Trials in Oncology Drug Development: Enhancing Precision with Bayesian Methods
July 11, 2024
Read More
Webinar – Project Optimus: Dose Escalation and Stratification Designs in Early Oncology Development
June 13, 2024
Read More
Webinar – Oncology Trials: External Control Arms and Bayesian Borrowing
May 31, 2024
Read More
White Paper – Adaptive Design Solutions for Rare Diseases Study Challenges
May 30, 2024
Read More
Webinar – Cytel Fit for Purpose (FFP) Real World Data Tool
March 6, 2024
Read More
Mitigating Challenges and Limitations in Rare Disease Study: Adaptive Design Solutions
February 21, 2024
Read More
Advanced Statistical Methodologies: Negative Binomial for Group Sequential Designs in Solara
December 21, 2023
Read More
Balancing priorities in therapeutics development: simulation-guided decision making
December 21, 2023
Read More
Using Cloud-Based Simulation Software to Optimize a Phase II Dose Finding Study
November 7, 2023
Read More
The Road to First-in-Human Trials: Insights from a Real-World Example
June 21, 2023
Read More
Comparative Effectiveness 4: Using Real World Evidence (RWE) in NMAs: Synthetic Control Arm’s and Quantitative Bias Analysis
June 1, 2023
Read More
Comparative Effectiveness 1: Comparative Effectiveness – methods and techniques for better decision making
January 23, 2023
Read More
Co-Clinical 3: Design considerations for early phase clinical trials of immuno-oncology drug
Claim your free 30-minute strategy session
Book a free, 30-minute strategy session with a Cytel expert to get advice on how to improve your drug’s probability of success and plot a clearer route to market.